Trial Profile
A long-term, follow-up study to evaluate the factors relevant to relapse in chronic hepatitis B patients after off-therapy of telbivudine and lamivudine
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Dec 2015
Price :
$35
*
At a glance
- Drugs Lamivudine (Primary) ; Telbivudine (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 22 Dec 2015 New trial record